The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy

• Main Authors: Abdulaziz Boqaeid (Author), Laila Layqah (Author), Amgad Alonazy (Author), Mutaz Althobaiti (Author), Al-zahraa Almahlawi (Author), Abdullah Al-Roqy (Author), Omar Baharoon (Author), Abdullah Alsaeedi (Author), Jinan Shamou (Author), Salim Baharoon (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The risk of infection including tuberculosis (TB) infection or reactivation during biological therapy with the current various clinical application is a major concern. This risk may be higher in countries endemic to TB. Our aim of this study is to determine the risk of TB infection in pa...